Cannabis
Skye Bioscience Stockholders Vote in Favor of Arrangement Agreement with Emerald Health Therapeutics, Inc.

Additional capital from Arrangement Agreement expected to fund Skye’s Phase 1 and 2 clinical studies of proprietary synthetic cannabinoid-derivative therapeutic targeting glaucoma
San Diego, California–(Newsfile Corp. – September 30, 2022) – Skye Bioscience, Inc. (OTCQB: SKYE) (“Skye” or the “Company”), a pharmaceutical company developing proprietary, synthetic cannabinoid derivatives to treat glaucoma and other diseases with significant unmet needs, reports that its stockholders voted in favor of all proposals presented at its special meeting held today, including the proposal to approve the proposed acquisition (the “Arrangement”) of Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQB: EMHTF) (“EHT”) by Skye. A total of 74% of shares outstanding were represented in person or by proxy at the special meeting.
Excluding the votes of (a) Emerald Health Sciences, Inc. or its affiliates, (b) directors or officers of EHT or Skye and (c) any immediate family members (as defined in Item 404 of Regulation S-K) of any of the officers or directors of EHT or Skye, the proposal to approve the Arrangement with EHT was approved by 97% of votes cast by stockholders for that proposal.
Stockholders also voted in favor of establishing the Company’s 2022 Employee Stock Purchase Plan, adopting and approving Skye’s Amended and Restated 2014 Omnibus Incentive Plan, and ratifying the appointment of Friedman LLP as SKYE’s independent registered public accounting firm for the fiscal year ending December 31, 2022.
Shareholders of EHT voted in favor of the Arrangement with Skye on August 19, 2022 and the Supreme Court of British Columbia issued a final order approving the Arrangement on August 25, 2022.
Skye and EHT continue to work diligently towards closing the Arrangement and plan to proceed with the closing as soon as practicable following the satisfaction of all remaining closing conditions, including obtaining conditional listing approval from the Canadian Securities Exchange.
Update provided by Skye CEO Punit Dhillon following Skye’s shareholder meeting
Punit Dhillon delivered the following remarks to shareholders immediately following the special meeting:
I want to thank Skye’s stockholders for their broad voting participation in this special meeting and for their resounding vote in favor of the resolution regarding the Arrangement Agreement with EHT.
Your support of the merger with EHT will provide us with additional financial resources that we expect to extend our operating runway to fund the Phase 1 that we are starting imminently and the Phase 2 study for which we are preparing our Investigational New Drug application to submit to the FDA by year end and planning to start in 2023.
I will again acknowledge and thank the EHT shareholders for their vote in favor of this transaction via their special meeting held on August 19th and which was approved by the British Columbia Supreme Court on August 25th.
We look forward to welcoming Emerald Health Therapeutics shareholders as new Skye stockholders as we continue on our path to develop our cannabinoid derivative drug candidates for important diseases with unmet needs.
Today is an important day, with both shareholder groups now aligned. So what comes next?
Skye’s agreement with Emerald Health Therapeutics called for the deal to be closed prior to October 15th. One key condition of closing is that Skye’s shares be listed to trade in Canada. We submitted our listing application to the Canadian Securities Exchange in late August and are in the process of satisfying their information requests. We have not set a closing date since there is uncertainty around the timing of their conditional approval. We will keep you updated.
Most exciting is that we are near to starting the company’s first-ever clinical study. We have met all of the regulatory requirements to start our Phase 1 trial for SBI-100 in Australia. Last week we announced that we had completed the production stage of our overall manufacturing process. We have just one final manufacturing step to complete, and that is quality and analytical testing to meet necessary standards. With receipt of that, we expect final drug product to be released and available for clinical use in October.
With our planned site visit to train clinical site staff and investigators in the second week of October, we expect to dose our first clinical trial subjects in November.
We are on the verge of turning the page to a whole new chapter of Skye’s advancement and our team is well-prepared and enthusiastic to take these next steps and is committed to make its best effort to implement a plan that can add value to the company.
About Skye Bioscience
Skye Bioscience is a pharmaceutical company unlocking the potential of cannabinoids through the development of its proprietary cannabinoid derivatives to treat diseases with significant unmet needs. The Company’s lead program, SBI-100 OE, is focused on developing a treatment for glaucoma, the world’s leading cause of irreversible blindness. For more information, please visit: www.skyebioscience.com.
CONTACT
Investor Relations Email: ir@skyebioscience.com Phone: (858) 410-0266
FORWARD-LOOKING STATEMENTS This letter contains forward-looking statements, including statements regarding our product development, business strategy, the timing of clinical trials, and commercialization of cannabinoid-derived therapeutics. Such statements and other statements in this press release that are not descriptions of historical facts are forward-looking statements that are based on management’s current expectations and assumptions and are subject to risks and uncertainties. If such risks or uncertainties materialize or such assumptions prove incorrect, our business, operating results, financial condition, and stock price could be materially negatively affected. In some cases, forward-looking statements can be identified by terminology including “anticipated,” “plans,” “goal,” “focus,” “aims,” “intends,” “believes,” “can,” “could,” “challenge,” “predictable,” “will,” “would,” “may” or the negative of these terms or other comparable terminology. We operate in a rapidly changing environment, and new risks emerge from time to time. As a result, it is not possible for our management to predict all risks, nor can we assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements the Company may make. Risks and uncertainties that may cause actual results to differ materially include, among others, our capital resources, uncertainty regarding the results of future testing and development efforts and other risks that are described in the Risk Factors section of Skye’s most recent annual or quarterly report filed with the Securities and Exchange Commission. Except as expressly required by law, Skye disclaims any intent or obligation to update these forward-looking statements.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/139109
Cannabis
CBD Skin Care Market Size is projected to reach USD 6466.43 million by 2030, growing at a CAGR of 32.15%: Straits Research

New York, United States, Sept. 20, 2023 (GLOBE NEWSWIRE) — Cannabidiol (CBD), derived from cannabis resin, is non-intoxicating. Cannabinoid (CBD) is most typically used with oils. CBD oil has anti-inflammatory, antioxidant, and skin-soothing properties. CBD oil is currently a popular ingredient in skin care and personal care products.
Since marijuana and cannabis-based cosmetics were legalized, CBD-infused skin care products have gained popularity. CBD-infused skin care products are popular because they relax. Anti-inflammatory and anti-oxidant properties make it a promising skin care ingredient. CBD-based skincare products can improve sleep and treat eczema, psoriasis, and acne. CBD-based skin care is popular among cosmetic brands. CBD-infused skin care is marketed as “natural cosmetics” CBD skin care products are expected to become popularity due to their versatility.
Get a Free Sample Copy of This Report @ https://straitsresearch.com/report/cbd-skin-care-market/request-sample
Global CBD Skin Care Market: DRIVERS
- Cannabis-Derived Skin Care Products Are Gaining Popularity
A surge in the working population around the world has increased spending power and awareness of the range of commodities on the market, boosting sales of quality products. These factors have led to growing global demand for natural and organic personal care items.
People are becoming increasingly familiar with the benefits of CBD skin care products, such as CBD oil in their daily coffee, using it to their skin to relieve pain, consuming it to relieve anxiety, and using it in their sex life.
- Social-Media’s Impact on Skin Diseases
Because of pollution and UV radiation, which can cause skin burns, blackening, and cancer, consumers are turning to CBD-infused cosmetics and skincare products. Consumers’ increased acquaintance with the newest skin care products helps boost sales. Companies increasingly use celebrities to sell their products and spend a lot on advertising.
YouTube and Instagram are important influences on today’s society. These portals help people find CBD skin care products. Rising customer awareness of the benefits and availability of new products should benefit the global market in the futur
Global CBD Skin Care Market: KEY FUTURE OPPORTUNITIES
- Technological Advances and Mergers Create New Opportunities
Recent scientific advances have resulted to innovative CBD extracts and combinations for skin care. CBD-infused goods from multinational firms are capturing new markets and establishing new cash streams. Avon plans to develop vegan skin care products with CBD oil in 2020. As the cannabis beauty industry grows, component approaches vary. These factors boost market growth.
A growing number of technological innovations are driven by a desire to lower production costs and to foster sustainable growth from 2022 to 2030.
Report Scope
Report Metric | Details |
Market Size by 2030 | USD 6466.43 million |
Market Size in 2021 | USD 526.09 million |
CAGR | 32.15% (2022-2030) |
Historical Data | 2020-2021 |
Base Year | 2022 |
Forecast Period | 2023-2031 |
Forecast Units | Value (USD million) |
Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
Segments Covered | By Technology, By Application, By Location |
Geographies Covered | North America, Europe, Asia-Pacific, LAME and Rest of the World |
Key Companies Profiled/Vendors | Kiehl’s LLC, Medical Marijuana, ENDOCA, Elixinol Global ltd, Lord Jones, Icanic Brands Company, Inc., LEEF Organics, The CBD Skincare Co, Kana Skincare, Apothecana, Josie Maran Cosmetics, FOLIUM BIOSCIENCES, CBD for life, Pacific Roots LLC, |
Key Market Opportunities | Technological Advances and Mergers Create New Opportunities |
Key Market Drivers | Cannabis-Derived Skin Care Products Are Gaining Popularity |
Buy Now Full Report @ https://straitsresearch.com/buy-now/cbd-skin-care-market
North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa make up the CBD Skin Care Market.
North America, which had over 45% of the market in 2021, is expected to grow quickest. Demand for CBD skin care products in North America is expected to continue high due to a large client base and the legalization of marijuana. Due to legalization in 33 states and DC, the US possesses the world’s largest cannabis market. Cannabis legalization and well-known beauty product makers should boost industry growth in the next years.
CBD-infused skin care products may fuel US customer demand. The FDA Regulation of Cannabidiol (CBD) Products prohibits marijuana but not hemp or cannabis. Manufacturing and selling CBD derivatives is lawful. CBD derivatives may be used as lotions, serums, and ointments.
Asia Pacific will grow rapidly in the future years. China, India, Japan, and Korea are expected to see substantial growth. J-beauty and K-beauty lead the worldwide skincare market, despite cannabis being illegal in Asia. This market is expected to grow rapidly in Asia.
China is one of the main manufacturers of cannabis made from hemp, and the World Bank and IMF expect it to monopolize the market throughout the predicted period. China allows the production and sale of CBD products with a maximum 0.3% THC content from cannabis Sativa fruit, seed oil, and leaf extract. This benefits its use in high-end skincare and luxury cosmetics.
Due to changing legislation, India’s CBD skin care market is growing. The Narcotic Drugs and Psychotropic Substances Act of 1985 says it’s unlawful to produce cannabis in the U.S., although states can allow its commercial or research cultivation.
Key Highlights
- The Global CBD Skin Care Market size is predicted to reach at USD 6466.43 million by 2030, increasing at a CAGR of 32.15% from 2022 to 2030.
- By Source,the Global CBD Skin Care Market is segmented into Hemp and Marijuana. CBD skin care products derived from hemp maintained the biggest market share.
- By Type,the Global CBD Skin Care Market is segmented into Oils, Creams & Moisturizers, Masks & Serums, Cleansers, and Others. In 2021, the market was led by skin care oils containing CBD.
- By Region,the Global CBD Skin Care Market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The market share is dominated by North America.
Major Players in Global CBD Skin Care Market
- Kiehl’s LLC
- Medical Marijuana
- ENDOCA
- Elixinol Global ltd
- Lord Jones
- Icanic Brands Company, Inc.
- LEEF Organics
- The CBD Skincare Co
- Kana Skincare
- Apothecana
- Josie Maran Cosmetics
- FOLIUM BIOSCIENCES
- CBD for life
- Pacific Roots LLC
- Ecogen labs
Get a Free Sample Copy of This Report @ https://straitsresearch.com/report/cbd-skin-care-market/request-sample
Global CBD Skin Care Market: Segmentation
BY SOURCE
- Hemp
- Marijuana
BY TYPE
- Oils
- Creams & Moisturizers
- Masks & Serums
- Cleansers
- Others
BY GEOGRAPHY
- North America
- Europe
- Asia Pacific (APAC)
- Latin America
- Middle East and Africa (MEA)
TABLE OF CONTENT
- EXECUTIVE SUMMARY
- RESEARCH SCOPE & SEGMENTATION
- Research Objectives
- Market Definition
- Limitations & Assumptions
- Market Scope & Segmentation
- Currency & Pricing Considered
- MARKET OPPORTUNITY ASSESSMENT
-
- Emerging Regions / Countries
- Emerging Companies
- Emerging Applications / End Use
- Investment Landscape
- New Business Models / Revenue Streams
- TAM
- MARKET TRENDS
-
- Drivers
- Market Warning Factors
- Latest Macro Economic Indicators
- Geopolitical Impact
- Human Factors
- Technology Factors
- MARKET ASSESSMENT
-
- Porters Five Forces Analysis
- Value Chain Analysis
- Sales And Distribution Channel Analysis
- Average Pricing Analysis
- Patent Analysis
- M & A Agreements & Collabration Analysis
- Export Import Analysis
- ESG TRENDS
- GLOBAL CBD SKIN CARE MARKET SIZE ANALYSIS
-
- Global CBD Skin Care Market Introduction
- By Source
-
-
- Introduction
-
-
-
-
- Source By Value
-
-
-
-
- Hemp
-
-
-
-
- By Value
-
-
-
-
- Marijuana
-
-
-
-
- By Value
-
-
-
- By Type
-
-
- Introduction
-
-
-
-
- Type By Value
-
-
-
-
- Oils
-
-
-
-
- By Value
-
-
-
-
- Creams & Moisturizers
-
-
-
-
- By Value
-
-
-
-
- Masks & Serums
-
-
-
-
- By Value
-
-
-
-
- Cleansers
-
-
-
-
- By Value
-
-
-
-
- Others
-
-
-
-
- By Value
-
-
- NORTH AMERICA MARKET ANALYSIS
-
- Introduction
- By Source
-
-
- Introduction
-
-
-
-
- Source By Value
-
-
-
-
- Hemp
-
-
-
-
- By Value
-
-
-
-
- Marijuana
-
-
-
-
- By Value
-
-
-
- By Type
-
-
- Introduction
-
-
-
-
- Type By Value
-
-
-
-
- Oils
-
-
-
-
- By Value
-
-
-
-
- Creams & Moisturizers
-
-
-
-
- By Value
-
-
-
-
- Masks & Serums
-
-
-
-
- By Value
-
-
-
-
- Cleansers
-
-
-
-
- By Value
-
-
-
-
- Others
-
-
-
-
- By Value
-
-
-
- U.S.
-
-
- By Source
-
-
-
-
- Introduction
- Source By Value
- Hemp
- By Value
- Marijuana
- By Value
- Introduction
-
-
-
-
- By Type
-
-
-
-
- Introduction
- Type By Value
- Oils
- By Value
- Creams & Moisturizers
- By Value
- Masks & Serums
- By Value
- Cleansers
- By Value
- Others
- By Value
- Introduction
-
-
-
- Canada
- EUROPE MARKET ANALYSIS
-
- Introduction
- By Source
-
-
- Introduction
-
-
-
-
- Source By Value
-
-
-
-
- Hemp
-
-
-
-
- By Value
-
-
-
-
- Marijuana
-
-
-
-
- By Value
-
-
-
- By Type
- Introduction
- By Type
-
-
-
- Type By Value
-
-
-
-
- Oils
-
-
-
-
- By Value
-
-
-
-
- Creams & Moisturizers
-
-
-
-
- By Value
-
-
-
-
- Masks & Serums
-
-
-
-
- By Value
-
-
-
-
- Cleansers
-
-
-
-
- By Value
-
-
-
-
- Others
-
-
-
-
- By Value
-
-
-
- U.K.
-
-
- By Source
-
-
-
-
- Introduction
- Source By Value
- Hemp
- By Value
- Marijuana
- By Value
- Introduction
-
-
-
-
- By Type
-
-
-
-
- Introduction
- Type By Value
- Oils
- By Value
- Creams & Moisturizers
- By Value
- Masks & Serums
- By Value
- Cleansers
- By Value
- Others
- By Value
- Introduction
-
-
-
- Germany
- France
- Spain
- Italy
- Russia
- Nordic
- Benelux
- Rest Of Europe
- APAC MARKET ANALYSIS
-
- Introduction
- By Source
-
-
- Introduction
-
-
-
-
- Source By Value
-
-
-
-
- Hemp
-
-
-
-
- By Value
-
-
-
-
- Marijuana
-
-
-
-
- By Value
-
-
-
- By Type
-
-
- Introduction
-
-
-
-
- Type By Value
-
-
-
-
- Oils
-
-
-
-
- By Value
-
-
-
-
- Creams & Moisturizers
-
-
-
-
- By Value
-
-
-
-
- Masks & Serums
-
-
-
-
- By Value
-
-
-
-
- Cleansers
-
-
-
-
- By Value
-
-
-
-
- Others
-
-
-
-
- By Value
-
-
-
- China
-
-
- By Source
-
-
-
-
- Introduction
- Source By Value
- Hemp
- By Value
- Marijuana
- By Value
- Introduction
-
-
-
-
- By Type
-
-
-
-
- Introduction
- Type By Value
- Oils
- By Value
- Creams & Moisturizers
- By Value
- Masks & Serums
- By Value
- Cleansers
- By Value
- Others
- By Value
- Introduction
-
-
-
- Korea
- Japan
- India
- Australia
- Taiwan
- South East Asia
- Rest Of Asia-Pacific
- MIDDLE EAST AND AFRICA MARKET ANALYSIS
-
- Introduction
- By Source
-
-
- Introduction
-
-
-
-
- Source By Value
-
-
-
-
- Hemp
-
-
-
-
- By Value
-
-
-
-
- Marijuana
-
-
-
-
- By Value
-
-
-
- By Type
-
-
- Introduction
-
-
-
-
- Type By Value
-
-
-
-
- Oils
-
-
-
-
- By Value
-
-
-
-
- Creams & Moisturizers
-
-
-
-
- By Value
-
-
-
-
- Masks & Serums
-
-
-
-
- By Value
-
-
-
-
- Cleansers
-
-
-
-
- By Value
-
-
-
-
- Others
-
-
-
-
- By Value
-
-
-
- UAE
-
-
- By Source
-
-
-
-
- Introduction
- Source By Value
- Hemp
- By Value
- Marijuana
- By Value
- Introduction
-
-
-
-
- By Type
-
-
-
-
- Introduction
- Type By Value
- Oils
- By Value
- Creams & Moisturizers
- By Value
- Masks & Serums
- By Value
- Cleansers
- By Value
- Others
- By Value
- Introduction
-
-
-
- Turkey
- Saudi Arabia
- South Africa
- Egypt
- Nigeria
- Rest Of MEA
- LATAM MARKET ANALYSIS
-
- Introduction
- By Source
-
-
- Introduction
-
-
-
-
- Source By Value
-
-
-
-
- Hemp
-
-
-
-
- By Value
-
-
-
-
- Marijuana
-
-
-
-
- By Value
-
-
-
- By Type
-
-
- Introduction
-
-
-
-
- Type By Value
-
-
-
-
- Oils
-
-
-
-
- By Value
-
-
-
-
- Creams & Moisturizers
-
-
-
-
- By Value
-
-
-
-
- Masks & Serums
-
-
-
-
- By Value
-
-
-
-
- Cleansers
-
-
-
-
- By Value
-
-
-
-
- Others
-
-
-
-
- By Value
-
-
-
- Brazil
-
-
- By Source
-
-
-
-
- Introduction
- Source By Value
- Hemp
- By Value
- Marijuana
- By Value
- Introduction
-
-
-
-
- By Type
-
-
-
-
- Introduction
- Type By Value
- Oils
- By Value
- Creams & Moisturizers
- By Value
- Masks & Serums
- By Value
- Cleansers
- By Value
- Others
- By Value
- Introduction
-
-
-
- Mexico
- Argentina
- Chile
- Colombia
- Rest Of LATAM
- COMPETITIVE ASSESSMENT
-
- CBD Skin Care Market Share By Manufacturers
- CBD Skin Care Market Ranking By Revenue For Manufacturers
- Competitive Dashboard
- Product Mapping
- MARKET PLAYERS ASSESSMENT
-
- Kiehl’s LLC
-
-
- Overview
- Business Information
- Revenue
- ASP
- Gross Margin
- Swot Analysis
- Recent Developmments
-
-
- Medical Marijuana
- ENDOCA
- Elixinol Global Ltd
- Lord Jones
- Icanic Brands Company, Inc.
- LEEF Organics
- The CBD Skincare Co
- Kana Skincare
- Apothecana
- Josie Maran Cosmetics
- FOLIUM BIOSCIENCES
- CBD For Life
- Pacific Roots LLC
- Ecogen Labs
- RESEARCH METHODOLOGY
-
- Research Data
-
-
- Secondary Data
-
-
-
-
- Major Secondary Sources
- Key Data From Secondary Sources
-
-
-
-
- Primary Data
-
-
-
-
- Key Data From Primary Sources
- Breakdown Of Primaries
-
-
-
-
- Secondary And Primary Research
-
-
-
-
- Key Industry Insights
-
-
-
- Market Size Estimation
-
-
- Bottom-Up Approach
- Top-Down Approach
- Market Projection
-
-
- Research Assumptions
-
-
- Assumptions
-
-
- Limitations
- Risk Assessment
- APPENDIX
-
- Discussion Guide
- Customization Options
- Related Reports
- DISCLAIMER
Table of Content and Figure @ https://straitsresearch.com/report/cbd-skin-care-market/toc
News Media
Global CBD Skin Care Market Extends at a Healthy CAGR of 32.15%
Have a Look at the Related Research Report
Skincare Products Market: Information by Product Type (Facial Care, Lip Care, and Body Care), Category (Premium Skincare Products and Mass Skincare Products), and Region- Forecast till 2030
Skincare Body Products Market: Information by Gender (Male and Female), Product (Face Creams and Moisturizers), and Region — Forecast till 2030
Organic Skin Care Market: Information by Product (Face Cleanser, Face Serum), Distribution Channel (Online, Supermarket/Hypermarket), and Region — Forecast till 2030
Facial Skincare Products Market: Information by Product Type (Facial Cleanser, Toner, Facial Serum, Eye Creams), Distribution Channel (Specialty Stores), and Region — Forecast till 2030
About Straits Research Pvt. Ltd.
Straits Research is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision-makers. Straits Research Pvt. Ltd. provides actionable market research data, especially designed and presented for decision making and ROI.
Whether you are looking at business sectors in the next town or crosswise over continents, we understand the significance of being acquainted with the client’s purchase. We overcome our clients’ issues by recognizing and deciphering the target group and generating leads with utmost precision. We seek to collaborate with our clients to deliver a broad spectrum of results through a blend of market and business research approaches.
For more information on your target market, please contact us below:
Phone: +1 646 905 0080 (the U.S.)
+91 8087085354 (APAC)
+44 203 695 0070 (the U.K.)
Email: sales@straitsresearch.com
Follow Us: LinkedIn | Facebook | Instagram | Twitter
Cannabis
Legal Cannabis Commercialization Bolsters Vacuum Oven Demand; Essential Role in Processing Extracts and Enhancing Safety Recognized

Dublin, Sept. 20, 2023 (GLOBE NEWSWIRE) — The “Vacuum Ovens Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028” report has been added to ResearchAndMarkets.com’s offering.
The global vacuum ovens market exhibited strong growth in 2022, reaching a total valuation of US$ 234.3 million. According to this report the market is poised for continued expansion, with expectations to reach US$ 343.2 million by 2028. This growth reflects a robust compound annual growth rate (CAGR) of 6.38% during the forecast period from 2023 to 2028.
Vacuum ovens, highly versatile equipment with applications in laboratory research, engineering, and industry, play a pivotal role in the heat treatment process. These ovens conduct heat treatment within an airtight vessel, allowing the creation of a vacuum within the chamber. This capability enables precise control over the heat treatment process and offers several advantages, including:
- Prevention of surface reactions like oxidation or decarburization.
- Removal of surface contaminants such as oxide films and residual traces of lubricants.
- Introduction of substances to the surface layers of the work.
- Removal of dissolved contaminating materials from metals through degassing.
The vacuum oven market’s growth is closely tied to the legalization of cannabis in many parts of the world and the subsequent commercialization of related products. Vacuum ovens play a crucial role for legal cannabis growers in processing cannabis extract BHOs (Butane Hash oil).
These ovens enable the production of purified oil extracts while reducing the risk of fires during the extraction process. Furthermore, vacuum ovens are used in the medical industry to eliminate potentially toxic chemicals from medical devices, including artificial heart valves, pacemakers, and joint implants. These ovens also find application in testing how devices respond to the high vacuum environment of space, making them valuable equipment for the aerospace industry.
Key Market Segmentation:
The global vacuum ovens market report by [Publisher Name] analyzes key trends within each sub-segment and provides forecasts at the global and regional levels for the period from 2023 to 2028. The market is segmented based on product type and application.
Product Type:
- < 200
- 200-300
- > 300
Application:
- Home Appliances
- Commercial Appliances
Regional Insights:
- North America
- Europe
- Asia Pacific
- Middle East and Africa
- Latin America
Competitive Landscape:
The report offers a comprehensive analysis of the competitive landscape, featuring key players such as Cole-Parmer, Memmert GmbH+Co.KG, MTI Corporation, Sheldon Manufacturing Inc, Thermo Fisher Scientific, Accumax India, BINDER GmbH, Cascade TEK, ESPEC, Grieve, JEIO, SalvisLab Renggli, Shanghai Hasuc Instrument, Ted Pella, and Yamato Scientific.
This report provides in-depth insights into the global vacuum ovens market, covering macro overviews, micro details of industry performance, recent trends, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, and more. It is a crucial resource for entrepreneurs, investors, researchers, consultants, business strategists, and anyone involved or planning to enter the vacuum ovens industry.
Key Questions Answered in This Report:
- How has the global vacuum ovens market performed and what are the growth prospects in the coming years?
- Which regions are the primary markets in the global vacuum ovens industry?
- What impact has COVID-19 had on the global vacuum ovens industry?
- How is the global vacuum ovens market segmented based on product type?
- What are the applications driving the global vacuum ovens market?
- What are the price trends for vacuum ovens?
- What is the value chain structure of the global vacuum ovens market?
- What are the key factors driving growth and challenges in the global vacuum ovens market?
- Who are the major players in the global vacuum ovens market, and what is the competitive landscape like?
- How are vacuum ovens manufactured?
Key Attributes:
Report Attribute | Details |
No. of Pages | 139 |
Forecast Period | 2022 – 2028 |
Estimated Market Value (USD) in 2022 | $254.3 Million |
Forecasted Market Value (USD) by 2028 | $343.2 Million |
Compound Annual Growth Rate | 5.1% |
Regions Covered | Global |
For more information about this report visit https://www.researchandmarkets.com/r/n83xum
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
Cannabis
Endexx Announces Amended Consolidated 10-Q/A: Quarterly Report for The Quarter Ending March 31, 2023, Increasing Year-Over-Year 1013%

Endexx Year Over Year Six Month Revenues Grew 528%
CAVE CREEK, AZ, Sept. 19, 2023 (GLOBE NEWSWIRE) — via NewMediaWire – Endexx® Corporation (OTCQB: EDXC), a provider of innovative plant-based wellness and nutritional products, announced today the filing of its amended, consolidated, audited 10-Q/A Quarterly report for the quarter ending March 31, 2023.
Endexx Milestones and Highlights for the quarter ending March 31, 2023
● Year-over-year quarterly revenues increased 1013% from $254,686 to $2,833,378.
● For the six months ended March 31, 2023, Endexx recorded a 528% increase in revenue, from $529,277 to $3,326,087 Year-Over-Year for the same period.
● Six-month losses year-over-year improved, March 31, 2023 were $2,584,678 compared to $4,426,299 in the same period of fiscal 2022.
“Consolidating the audited financials and integrating Hyla’s operations into Endexx, we’ve catapulted into an era marked by unprecedented growth, painting Fiscal 2023 as a canvas of resurgence and robust expansion amidst a two-year stagnation in the cannabis and hemp industry,” said Todd Davis. “This synergy has not just revitalized our foothold in the domestic market but has also catapulted us onto the global stage, significantly multiplying our retail presence into 11 countries, particularly during the initial half of Fiscal 2023.”
www.endexx.com & www.cbdunlimited.com
About Endexx Corporation
Endexx Corporation develops and distributes all natural, plant-derived wellness products and topical skincare products. Its products vary from balms, creams, lotions, butters, masks, scrubs, and oils, all with the shared purpose of healthy skin and grooming wellness. The science behind these products involves a decade of clinical research in the field and lab work to provide functional formulation with ingredients for optimal absorption and support of skin health. www.endexx.com
Hyla currently markets its proprietary non-nicotine, guarana and L-Dopa-based vape products in a wide variety of flavors. The Hyla device is the first non-nicotine vape product to be produced in this manner in the United States and provides an unprecedented 4,500 puffs per device. Hyla is currently being distributed in 10 countries and has signed distribution agreements with an additional nine countries. www.tryhyla.com
Safe Harbor Statement Under the Private Securities Litigation Reform Act of 1995
We caution that any forward-looking statements (as such term is defined in the U.S. Private Securities Litigation Reform Act of 1995) contained in this press release or made by us, our management, or our spokespeople involve risks and uncertainties and are subject to change based on various factors, many of which are beyond our control. Accordingly, our future performance and financial results may differ materially from those expressed or implied in any such forward-looking statements. Forward-looking statements include, without limitation, statements regarding our future operating results, the implementation and impact of our strategic plans, and our ability to meet environmental, social, and governance goals. Words such as “estimate,” “commit,” “target,” “goal,” “project,” “plan,” “believe,” “seek,” “strive,” “expect,” “anticipate,” “intend,” “potential” and any similar expressions may identify forward-looking statements. Risks associated with the following factors, among others, could affect our financial performance and cause actual results to differ materially from those expressed or implied in any forward-looking statements.
Except as may be required by law, we assume no obligation and do not intend to make publicly available any update or other revisions to any of the forward-looking statements contained in this press release to reflect circumstances existing after the date of this press release or to reflect the occurrence of future events, even if experience or future events make it clear that any expected results expressed or implied by those forward-looking statements will not be realized. More information on potential factors that could affect our results is included “Risk Factors” in our amended Annual Report on Form 10-K/A filed with the Securities and Exchange Commission on June 9, 2023.
No Offer or Solicitation. This communication shall not constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offering of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended, and, where applicable, the requirements under the securities laws of any other applicable jurisdiction.
For further information, please contact:
Endexx Corporation
IR@Endexx.com
480-595-6900
-
Increasing2 weeks ago
With Increasing Legal Acceptance Global Cannabis Market Projected To Reach $51 Billion In 2023
-
Cannabis1 week ago
Endexx Announces Company Presentation in Michigan on October 2nd, 2023
-
Latest News2 weeks ago
Major Cannabis Industry Media Outlets Recognize CFCR’s Efforts to Support FDA Regulation of CBD
-
Cannabis1 week ago
Lucy Scientific Discovery Inc. Announces Acquisition of BlueSky Wellness Inc. in All-Stock Transaction
-
Cannabis1 week ago
Endexx Provides Insight on Possible New Federal Cannabis Regulations
-
Cannabis1 week ago
Industrial Hemp Market to Reach USD 31.98 Billion by 2030 | At a 22.11% of CAGR
-
Market1 week ago
Industrial Hemp Market size worth USD 23.20 Billion, Globally, by 2030 at 14.05% CAGR: Verified Market Research®
-
Cannabis1 week ago
Hemp, Inc. Reports: Global Natural Fiber Composites (Hemp, Kenaf, and Flax) Market Set to Reach $424 Million by 2028